Insulin Pumps, Continuous Glucose Monitors, Closed Loop Insulin Delivery Systems and Associated Products

This is a contract result notice, not an open opportunity. Details from the official award data.

The procurement contact named on the official notice.

In January 2022 NHS Supply Chain launched a non-exclusive Framework Agreement for supply to NHS Supply Chain customer base of Insulin Pumps Continuous Glucose Monitoring Closed Loop Insulin Delivery Systems and Associated Products.

The Framework Agreement provides one ordering platform for all technologies, the objective to award broadly across the Framework Agreement to ensure continuity of supply for all key product areas and to also allow optimisation opportunities to be identified.

In accordance with Section 3 of the ITT that was published in June 2021, NHS Supply Chain took the decision to open the Framework Agreement to new Applicants in 2022 to ensure the Framework Agreement continued to offer the broadest possible range of products to the NHS, as well as ensuring any new technologies and innovations in this product area are made available via the Framework Agreement.

NHS Supply Chain has taken the decision to open the Framework Agreement to new Applicants again, to ensure the Framework Agreement continues to offer the broadest possible range of products to the NHS, as well as ensuring any new technologies and innovations in this product area are made available via the Framework Agreement.

Applicants successfully awarded to the Framework Agreement during this Agile Tender are awarded with the incumbent suppliers who were awarded to the Framework Agreement following the previous tendering exercise (Contract Award Notice reference: 2022/S 000-000260 and suppliers awarded following the Agile Tendering exercise (Contract Award Notice reference 2022/S 000-035953).

Notices can be viewed at: https://www.gov.uk/find-tender).

This agreement is for the supply of Insulin Pumps, Continuous Glucose Monitoring (CGM) devices, Applications or software to enable the function of Closed Loop Insulin Delivery Systems and also for the dedicated consumables and accessories for the products listed above.

The Framework Agreement was launched in January 2022 with an initial term of 24 months with an option to extend incrementally for up to a total period of 48 months.

Applicants awarded to the Framework Agreement during this Agile Tender will therefore be awarded for the remaining period of 24 months.

Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.